BTG3 and autoimmune polyendocrinopathy: Higher PASI scores at the initiation of biologics (HR 1.11, P = 0.01) and ANA positivity, specifically with titers exceeding 320x (HR 4.67, P = 0.04), were statistically significant predictors in association with developing APS autoantibodies.